, Volume 71, Issue 2, pp 165-167

Cefotaxime desensitization

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


We report the successful desensitization to cefotaxime in a patient with severe lumbar osteomyelitis of unknown bacteriology and hypersentivity to the drug. Desensitization was carried out because of the unknown bacteriology, the favorable response to cefotaxime at that time, and hypersensitivity to other antibiotics. On the first day the patient received 1 mg cefotaxime intravenously. The dose was increased for 13 successive days to 4 g cefotaxime intravenously per day. No allergic reaction occurred during densitization or within 4 weeks of observation under this therapy. Patients with severe infections of unknown bacteriology might benefit from desensitization if therapy with a second-choice antibiotic is impossible.

Dedicated to Prof. Dr. N. Zöllner on the occasion of his 70th birthday